|
Select
from the list below to
view the abstracts from
the 2007 workshop in
Kos, Greece. The abstracts are
in PDF format and are
organized by topic.
Corresponding papers
from this conference are
also published in
Haematologica, Volume
92, no. 6 supplement 2,
June 2007. These
abstracts can also be
accessed by following
the links in the Kos
program of events section.
The browser you are using will not work with the contents of this page, we recommend that you update to a newer browser or check to make sure that JavaScript is enabled.
Genetics, Pathophysiology and Staging System
Biologic and clinical overlap of IgM-secreting lymphomas; Focus on Waldenstrom’s Macroglobulinemia
G.A. Pangalis, T. Tzenou, C. Kalpadakis, T.P. Vassilakopoulos, E.M. Dimitriadou, S. Sachanas, L. Petrikkos, M.K. Angelopoulou, M.P. Siakantaris, M.N. Dimopoulou, S.I. Kokoris, P. Tsaftaridis, P. Panayiotidis, M.C. Kyrtsonis
Tracking The Malignant Cell Of Origin In Waldenstrom’s Macroglobulinemia
S.S. Sahota, G. Babbage, M. Townsend, N.J. Weston-Bell, & F.K. Stevenson
Immunoglobulin Gene Rearrangements In Waldenström’s Macroglobulinemia
R. García-Sanz, P. Martín-Jiménez, E.M. Ocio, N.C. Gutiérrez, M. González, J.F. San Miguel
Inherited And Acquired Mutations In Waldenstrom’s Macroglobulinemia (WM): WM And MM Have Close Genetic Relationships Not Shared With B-CLL
L.M. Pilarski, S. Adamia, A. Reichert, A. Ghosh1 M.J. Mant, T. Reiman, S.P. Treon, A.R. Belch
Genetics And Genomics Of Waldenström Macroglobulinemia
R. Fonseca, E. Braggio
IgM MGUS And Asymptomatic Waldenström’s Macroglobulinemia: Prognostic Factors And Evolution
E. Morra, C. Cesana, L. Barbarano, M. Varettoni, P. Bernuzzi, A. Tedeschi, L. Cavanna, M. Lazzarino
International Prognostic Scoring System For Waldenström’s Macroglobulinemia
P. Morel, A. Duhamel, P. Gobbi, M. Dimopoulos, M. Dhodapkar, J. McCoy, E. Ocio, R. Garcia-Sanz, V. Leblond, R. Kyle, B. Barlogie, G. Merlini
Novel Treatment Approaches, Treatment of Advanced Disease
Proteomic Analysis In Waldenstrom Macroglobulinemia
I. Ghobrial
The gene expression signature of clonal cells from Waldenstrom's Macroglobulinemia: differences and commonalities with the normal cell counterpart and other related lymphoproliferative disorders
Gutierrez N.C., Ocio E.M., Delgado M., de las Rivas J., Ferminan E., Martin-Jimenez P., Arcos M.J., Hernandez J.M., Garcia-Sanz R., San Miguel J.F.
Gene expression profiling of Waldenstrom's Macroglobulinemia reveals genes that may be related to disease pathogenesis
Hatjiharissi E., Zhan F., Adamia, S., Ciccarelli B.T., Cao Y., Xu, L., Hu H., Hunter Z.R., Patterson J.R., Ghobrial I.M., Barlogie B., Shaughnessy JD Jr., Treon SP
Novel splice variant transcript of Siva in Waldenstrom's Macroglobulinemia
Hatjiharissi E., Adamia S., Cao Y., Ciccarelli BT., Xu L., Treon SP
Aberrant post-transcriptional regulation of TNF family members and their adaptor molecules essential to B-cell growth and survival in Waldenstrom's Macroglobulinemia
Adamia S., Xu L., Hatjiharissi E., Ciccarelli BT., Cao Y., Sacco A., Hunter ZR., Patterson CJ., Treon SP
The functional role of CD27-CD70 interactions in Waldenstrom's Macroglobulinemia
Ciccarelli BT., Hatjiharissi E., Ho AW, Branagan AR, Hunter ZR, Adamia S., Leleu X., Xu L., O'Connor KE, Manning RJ, Santos DD, Patterson CJ, Soumerai JD, Munshi NC, McEarchern JA, Grewal IS, Treon SP
Serum concentrations of angiogenic cytokines in Waldenstrom's Macroglobulinemia: The ratio of angiopoietin-1 to angiopoietin-2 and angiogenin correlate with disease severity
Anagnostopoulos A., Eleftherakis-Papaiakovou V., Zervas K., Kastritis E., Tsionos K., Bamias A., Dimopoulos M.A., Terpos E.
Use of the immunomodulators thalidomide and lenalidomide to augment rituximab clinical activity in Waldenstrom's Macroglobulinemia
Soumerai J., Branagan A., Hunter Z., Patterson C., Hatjiharissi E., Treon S.
Allogeneic stem cell transplantation (ALLO-SCT) in Waldenstrom's Macroglobulinaemia (WM). An analysis of 106 cases from the european bone marrow registry (EBMT)
C. Kyriakou, C. Canals, G. Taghipour, JJ. Cornelissen, R. Willemze, G. Socie, K. Thompson, H. Greinix, JL. Harousseau, N. Ifrah, J. Kienast, R. Hamladji, M. Kazmi, P. Jacobs, A. Sureda, N. Schmitz
Increased incidence of disease transformation and development of MDS/AML in Waldenstrom's Macroglobulinemia (WM) patients treated with nucleoside analogues
Xavier Leleu, Robert Manning, Jacob Soumerai, Zachary R. Hunter, Anne-Sophie Moreau, Evdoxia Hatjiharissi, Aldo Roccaro, Antonio Sacco, Sophia Adamia, Christopher J. Patterson, Irene M. Ghobrial, Steven P. Treon
Clinical Profile And Treatment Outcome In 103 Patients With AL Amyloidosis Associated With IgM Paraproteinaemia
Wechalekar AD, Gillmore JD, Lachmann HJ, Offer M, Hawkins PN
Resveratrol exerts antiproliferative effect and induces apoptosis in Waldenström's Macroglobulinemia
Roccaro A.M., Leleu X., Moreau A.S., Patterson C.J., Xu L., Jia X., Ngo H., Sacco A., Cao J., Ciccarelli B., Manning R., Adamia S., Hatjharissi E., Russo D., Vacca A., Dammacco F., Ghobrial I.M., Treon S.P.
Genomic mutations in the April/Taci/Traf pathway in Waldenstrom'as Macroglobulinemia
Hunter Z.R., Leleu X., Adamia S., Hatjiharissi E., Xu L., Ciccarelli B., Ioakimidis L., Moreau A.S., O'Connor K.E., Soumerai J., Patterson C., Hamilton S., Verselis S., Fox E.A., Treon S.P.
|
